Quantcast
Last updated on April 23, 2014 at 16:13 EDT

Latest Exenatide Stories

2013-11-16 23:02:02

The Firm is currently investigating Byetta lawsuits that allege an association between use of Byetta and pancreatic cancer, as well as pancreatitis and thyroid cancer. New York, New York (PRWEB) November 16, 2013 Dozens of Byetta lawsuits, (http://www.byettalawsuit2013.com/) as well as other product liability claims involving Januvia, Victoza and other diabetes drugs known as incretin mimetics, continue to move forward in a federal multidistrict litigation now underway in U.S. District...

2013-11-12 23:00:24

DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) November 12, 2013 The diabetes drug safety center at DrugRisk.com is alerting patients taking the medications Januvia or Janumet of new information on the site. A federal court overseeing a growing number of lawsuits alleging drugs like these caused pancreatic cancer has set the next hearing for next week. The formal case is...

2013-11-12 12:27:31

JERUSALEM, November 12, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the last patient has left the clinic from its U.S. FDA Phase 2a safety study for ORMD-0801, an oral insulin capsule based on the Company's platform Protein Oral Delivery (POD(TM)) technology. The Phase 2a trial, which enlisted 30 type 2...

2013-11-08 23:24:49

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) November 08, 2013 The diabetes drug resource center at DrugNews.net is announcing a new resource site for patients taking the medication Byetta. The site will track the latest research and safety warnings, as well as court records from lawsuits alleging drugs like Byetta caused cancer*. The DrugNews center was...

2013-11-08 23:01:20

The Firm is evaluating potential Byetta lawsuits alleging an association between the use of Byetta and pancreatic cancer. New York, New York (PRWEB) November 08, 2013 Byetta lawsuits (http://www.byettalawsuit2013.com/) and other product liability claims involving the use of diabetes drugs known as incretin mimetics continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of California, Bernstein Liebhard LLP reports. According to court...

2013-11-05 23:32:24

Judge issues schedule in consolidated federal cases alleging that diabetes medications Byetta, Januvia, Janumet and Victoza cause pancreatic cancers. Resource4thePeople announce continuation of free consultations for consumers seeking legal options for compensation. San Diego, CA (PRWEB) November 05, 2013 http://www.resource4thepeople.com/defectivedrugs/januvia.html Resource4thePeople announced today that it providing consumers who are following the progress of lawsuits alleging that a...

2013-11-05 23:31:42

Commack, New York law firm, Rudolph F.X. Migliore, P.C., is accepting cases from individuals who took the prescription medication Januvia, Janumet, Byetta or Victoza and later developed pancreatic cancer. Commack, NY (PRWEB) November 05, 2013 New York law firm Rudolph F. X. Migliore, P.C. has announced they are now accepting cases on behalf of individuals who used the type-2 diabetes medication Januvia, Janumet, Byetta or Victoza and who later developed pancreatic or thyroid cancer....

2013-11-05 23:30:17

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) November 05, 2013 The diabetes drug safety center at DrugNews.net is advising patients taking the medications Januvia or Janumet of updated information on the site. The latest court records from a special federal court show a growing number of patients alleging drugs like Januvia caused cancer*. DrugNews...

2013-10-31 12:26:44

Surveyed Endocrinologists Indicate a Higher Mean Interest Level for Tresiba versus Dapagliflozin, According to a New Report from BioTrends Research Group EXTON, Pa., Oct. 31, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, among surveyed endocrinologists and primary care physicians (PCPs), Janssen Pharmaceuticals' Invokana captures a small percentage of type 2 diabetes patient...

2013-10-30 23:23:12

The Firm is actively investigating potential Januvia lawsuit claims on behalf of individuals who allegedly developed pancreatitis, pancreatic cancer or thyroid cancer as a result of taking the Type 2 diabetes medication. New York, NY (PRWEB) October 30, 2013 A federal Januvia lawsuit litigation (http://www.januvialawsuithelp.com/) continued to progress in October with an initial status conference to discuss matters related to claims over the Type 2 diabetes drug, as well as other...


Latest Exenatide Reference Libraries

36_67c6fec75293d7e1e91a0c52aa692cf7
2005-06-22 14:17:05

The Gila monster (Heloderma suspectum) is one of the two known species of venomous lizards. This lizard lives in the deserts of the southwestern USA and northwestern Mexico. It is a heavy, slow moving lizard and can measure up to 2 feet (60 cm) in length. Its skin has the appearance of beads in the colors black, pink, orange, and yellow, laid down in intricate patterns across the animal's body. Unlike a snake, the Gila monster envenomates its victim through grooves in the teeth of its...

More Articles (1 articles) »